HMVRX
Price
$17.05
Change
+$0.19 (+1.13%)
Updated
Jul 17 closing price
Net Assets
1.14B
VMVIX
Price
$65.67
Change
+$0.51 (+0.78%)
Updated
Jul 17 closing price
Net Assets
30.57B
Interact to see
Advertisement

HMVRX vs VMVIX

Header iconHMVRX vs VMVIX Comparison
Open Charts HMVRX vs VMVIXBanner chart's image
Hartford MidCap Value R3
Price$17.05
Change+$0.19 (+1.13%)
VolumeN/A
Net Assets1.14B
Vanguard Mid-Cap Value Index Investor
Price$65.67
Change+$0.51 (+0.78%)
VolumeN/A
Net Assets30.57B
HMVRX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HMVRX vs. VMVIX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVRX is a Hold and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. HMVRX (1.14B). VMVIX pays higher dividends than HMVRX: VMVIX (2.14) vs HMVRX (0.31). HMVRX was incepted earlier than VMVIX: HMVRX (15 years) vs VMVIX (19 years). HMVRX (1.48) is less costly to investors than VMVIX (0.19). HMVRX is a more actively managed with annual turnover of: 132.00 vs. VMVIX (19.00). HMVRX has a lower initial minimum investment than VMVIX: HMVRX (0) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 4.95 vs. HMVRX (-8.75). VMVIX return over 5 years is better than : 67.64 vs. HMVRX (31.51).
HMVRXVMVIXHMVRX / VMVIX
Total Expense Ratio1.480.19779%
Annual Report Gross Expense Ratio1.480.19779%
Fund Existence15 years19 years-
Gain YTD0.2972.38012%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B30.6B4%
Annual Yield % from dividends0.312.1415%
Returns for 1 year-8.754.95-177%
Returns for 3 years3.0627.9311%
Returns for 5 years31.5167.6447%
Returns for 10 years4.6585.725%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVLA31.232.81
+9.89%
Palvella Therapeutics Inc
TDACU10.43N/A
N/A
Translational Development Acquisition Corp
ALSN88.92-0.13
-0.15%
Allison Transmission Holdings
EXPI10.19-0.12
-1.16%
eXp World Holdings
NVNI0.34-0.01
-4.12%
Nvni Group Limited